Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Fleming, Jessica L ^a   Gable, Dustin L ^b   Samadzadeh Tarighat, Somayeh ^b   Cheng, Luke ^b   Yu, Lianbo ^b   Gillespie, Jessica L ^a   Toland, Amanda Ewart ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

MicroRNA; miR 1; Skin cancer

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 124A 3; MICRORNA 133A; MICRORNA 134; MICRORNA 206; MICRORNA 9 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAG4 GENE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ETS1 GENE; FEMALE; GENE; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SKIN CARCINOMA; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 84877136604     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.68     Document Type: Article

References (60)

1. Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC. 2007. BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. Clinical Cancer Research 13:6585-6592
2. Beta D,Wilson M, Gabow A,Marks DS, Sanders C. 2008. The microRNA.org resource: targets and expression. Nucleic Acids Research 36:D149-D153.
3. Chen JF,Mandel EM, Thomson JM,Wu Q, Callis TE, Hammond SM, Conlon FL,Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics 38:228-233
4. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M,McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF. 2009. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. American Journal of Pathology 174:736-745
5. Ciardiello F, Tortora G. 2008. EGFR antagonists in cancer treatment. New England Journal of Medicine 358:1160-1174
6. Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 10:704-714
7. Darido C, Georgy SR,Wilanowski T, Dworkin S, Auden A, Zhao Q, Rank G, Srivastava S, Finlay MJ, Papenfuss AT, Pandolfi PP, Pearson RB, Jane SM. 2011. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 20:635-648
8. Datta J, Kutay H, Nasser MW, Nuovo GJ,Wang B,Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST. 2008. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Research 68:5049-5058
9. Dejager L, Libert C,Montagutelli X. 2009. Thirty years of Mus SPRETus: a promising future. Trends in Genetics 25:234-241
10. Dittmer J. 2003. The biology of the Ets1 proto-oncogene. Molecular Cancer 2:29
11. Doong H, Vralias A, Kohn EC. 2002. What's in the 'BAG'?-A functional domain analysis of the BAG family proteins. Cancer Letters 188:25-32
12. Djuranovic S, Nahvi A, Green A. 2011. A parsimonious model for gene regulation by miRNAs. Science 331:550-553
13. Dziunycz P, Iotzova-Weiss G, Eloranta JJ, Lauchli S, Hafner J, French LE, Hofbauer GFL. 2010. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. Journal of Investigative Dermatology 130:2686-2689
14. Gatti DM, Lu L,Williams RW, Sun W,Wright FA, Threadgill DW, Rusyn I. 2011. MicroRNA expression in the livers of inbred mice. Mutation Research 714:126-133
15. Gordon A, Glazko G, Qiu X, Yakovlev A. 2007. Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. The Annals of Applied Statistics 1:179-190
16. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F,Wernert N. 2005. Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion, and anchorage-independent growth. Oncogene 24:5384-5388
17. Hahne JC, Kummer S, Heukamp LC, Fuchs T, Gun M, Langer B, Von Ruecker A,Wernert N. 2009. Regulation of protein tyrosine kinases in tumour cells by the transcription factor Ets-1.International Journal of Oncology 35:989-996.
18. Huang H, Eversley CD, Threadgill DW, Zou F. 2007. Bayesian multiple quantitative trait loci mapping for complex traits using markers of the entire genome. Genetics 176:2529-2540
19. Hudson RS, Yi M, Esposito D,Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs S. 2012. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Research 40:3689-3703
20. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M. 2012. The functional significance of miR-1 and miR-133a in renal cell carcinoma. European Journal of Cancer 4:827-836
21. Keehn CA, Smoller BR,Morgan MB. 2004. Ets-1 immunohistochemical expression in non-melanoma skin cancer. Journal of Cutaneous Pathology 31:8-13
22. Knight ZA, Lin H, Shokat KM. 2010. Targeting the cancer kinome through polypharmacology. Nature Reviews in Cancer 10:130-137
23. Li D, Yang P, Li H, Cheng P, Zhang L,Wei D, Su X, Peng J, Gao H, Tan Y, Zhao Z, Li Y, Qi Z, Rui Y, Zhang T. 2012. MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Science 91:440-447
24. Liu CG, Calin GA,Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. 2004. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proceedings of the National Academy of Sciences of the United States of America 101:9740-9744
25. Liu CG, Calin GA, Volinia S, Croce CM. 2008. MicroRNA expression profiling using microarrays. Nature Protocols 3:563-578
26. Manenti G, Gariboldi M, Elango R, Fiorino A, De Gregorio L, Falvella FS, Hunter K, Housman D, Pierotti MA, Dragani TA. 1996. Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Nature Genetics 12:455-457
27. McCarthy JJ. 2008. MicroRNA-206: the skeletal muscle-specific myomiR. Biochimica et. Biophysica Acta 1779:682-691
28. Medina PP, Slack FJ. 2008. microRNAs and cancer: an overview. Cell Cycle 7:2485-2492
29. Montagut C, Settleman J. 2009. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Letters 283:125-134
30. Nagarajan P, Parikh N, Garrett-Sinha LA, Sinha S. 2009. Ets1 induces dyplastic changes when expressed in terminally-differentiating squamous cell epidermal cells. PLoS ONE 4:e4179
31. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A. 1995. Distinct genetic loci control development of benign and malignant skin tumors in mice. Nature Genetics 10:424-429
32. Nasser MW, Datta J, Nuovo G, Kutay H,Motiwala T,Majumder S,Wang B, Suster S, Jacob ST, Ghoshal K. 2008. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigeneic property of lung cancer cells and their sensitization to doxurubicin-induced apoptosis by miR-1. Journal of Biological Chemistry 283:33394-33405
33. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. 2011. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. International Journal of Oncology 39:1099-1107.
34. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto Y, Seki N. 2012a. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2:29-44.
35. Nohata N, Hanazawa T, Enokida H, Seki N. 2012b. MicroRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3:9-21.
36. Ozawa F, Friess H, Zimmerman A, Kleef J, Buchler MW. 2000. Enhanced expression of silencer of death domains (SODD/BAG-4) in pancreatic cancer. Biochemical and Biophysical Research Communications 271:409-413
37. Pande P,Mathur M, Shukla NK, Ralhan R. 1999. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. Journal of Pathology 189:40-45
38. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM,Manak JR, Shivdasani R Coetzee GA, Freedman ML. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nature Genetics 41:882-884
39. Quigley DA, To MD, Perez-Losada J, Pelorosso FG,Mao JH, Nagase H, Ginzinger DG, Balmain A. 2009. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458:505-508
40. Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S. 2012. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Molecular Cancer Research 10:504-515
41. Roberts PJ, Der CJ. 2007. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-3310
42. Saeki H, Kuwano H, Kawaguchi H, Ohno S, Sugimachi K. 2000. Expression of Ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 89:1670-1676
43. Saeki H, Oda S, Kawaguchi H, Ohno S, Kuwano H,Maehara Y, Sugimachi K. 2002. Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. International Journal of Cancer 98:8-13
44. Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV, Hyslop T, Demant P, Croce CM, Siracusa LD. 2007. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proceedings of the National Academy of Sciences of the United States of America 104:8017-8022
45. Shyu AB,Wilkinson MF, van Hoof A. 2008.Messenger RNA regulation: to translate or to degrade. The EMBO Journal 27:471-481
46. Siomi H, Siomi MC. 2010. Posttranscriptional regulation of microRNA biogenesis in animals. Molecular Cell 38:323-332
47. Smith AM, Findlay VJ, Bandurraga SG, Kistner-Griffin E, Spruill LS, Liu A, Golshayan AR, Turner DP. 2012. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Carcinogenesis 33:572-580
48. Spain SL, Carvajal-Carmona LG, Howarth KM, Jones AM, Su Z, Cazier JB,Williams J, Aaltonen LA, Pharoah P, Kerr DJ, Cheadle J, Li L, Casey G, Vodicka P, Sieber O, Lipton L, Gibbs P,Martin NG,Montgomery GW, Young J, Baird PN,Morreau H, van Wezel T, Ruiz-Ponte C, Fernandez-Rozadilla C, Carracedo A, Castells A, Castellvi-Bel S, Dunlop M, Houlston RS, Tomlinson IP. 2012. Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13. Human Molecular Genetics 15:934-946
49. Tang Y, Zheng J, Sun Y,Wu Z, Liu Z, Huang G. 2009. MicroRNA-1 regulated cardiomyocyte apoptosis by targeting Bcl-2. International Heart Journal 50:377-387
50. Tominaga E, Yuasa K, Shimazaki S, Hijikata T. 2013. MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties. Experimental Cell Research 319:77-88
51. Villa-Morales M, Santos J, Fernandez-Piqueras J. 2006. Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiationinduced thymic lymphoma. Oncogene 25:2022-2029
52. Wei W, Hu Z, Fu H, Tie Y, Zhang H,Wu Y, Zheng X. 2012. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Oncology Reports 28:701-706.
53. Wery M, Kwapisz M,Morillon A. 2011. Noncoding RNAs in gene regulation. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 3:728-738
54. Yamasaki T, Yoshino H, Enokkida H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Fuse M, Seki N, Nakagawa M. 2012. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. International Journal of Oncology 40:1821-1830.
55. Yan D, Dong Xda E, Chen X,Wang L, Lu C,Wang J, Qu J, Tu L. 2009. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. Journal of Biological Chemistry 284:29596-29604
56. Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP. 2010. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Research 70:8487-8497
57. Yoshino H, Enokida H, Chiyomaru T, Tatarano S, Hidaka H, Yamasaki T, Gotannda T, Tachiwada T, Nohata N, Yamane T, Seki N, Nakagawa M. 2012. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochemical and Biophysical Research Communications 417:588-593
58. Yu L, Gulati P, Fernandez S, Pennell M, Kirschner L, Jarjoura D. 2011. Fully moderated t-statistic for small sample size gene expression arrays. Statistical Applications in Genetics and Molecular Biology 10:1-22, article 42
59. Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX, Lin SG, Li Y. 2008. Glucose induced apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochemical and Biophysical Research Communications 376:548-552
60. Zoumpourlis V, Solakidi S, Papthoma A, Papaevangeliou D. 2003. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis. Carcinogenesis 24:1159-1163